CRIVELLARO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 10.183
AS - Asia 5.876
EU - Europa 4.950
SA - Sud America 896
Continente sconosciuto - Info sul continente non disponibili 566
AF - Africa 140
OC - Oceania 35
Totale 22.646
Nazione #
US - Stati Uniti d'America 9.577
SG - Singapore 1.887
IT - Italia 1.595
CN - Cina 1.233
VN - Vietnam 1.209
BR - Brasile 707
DE - Germania 640
HK - Hong Kong 623
RU - Federazione Russa 614
CA - Canada 494
SE - Svezia 457
IE - Irlanda 320
GB - Regno Unito 269
FR - Francia 222
UA - Ucraina 200
IN - India 176
BD - Bangladesh 145
AT - Austria 116
FI - Finlandia 95
TR - Turchia 90
ES - Italia 87
KR - Corea 74
IQ - Iraq 73
DK - Danimarca 63
NL - Olanda 60
AR - Argentina 59
PL - Polonia 58
MX - Messico 55
ID - Indonesia 53
JP - Giappone 49
EC - Ecuador 42
ZA - Sudafrica 40
PK - Pakistan 37
AU - Australia 33
CH - Svizzera 32
PH - Filippine 30
BE - Belgio 28
SA - Arabia Saudita 24
CO - Colombia 23
KE - Kenya 23
UZ - Uzbekistan 23
CZ - Repubblica Ceca 22
VE - Venezuela 21
MA - Marocco 19
JM - Giamaica 18
JO - Giordania 16
PY - Paraguay 16
MY - Malesia 15
CL - Cile 13
BG - Bulgaria 11
EG - Egitto 11
LT - Lituania 11
PS - Palestinian Territory 11
TH - Thailandia 11
AE - Emirati Arabi Uniti 10
OM - Oman 10
PT - Portogallo 10
TN - Tunisia 10
AZ - Azerbaigian 9
IR - Iran 8
RO - Romania 8
TW - Taiwan 8
EU - Europa 7
HN - Honduras 7
UY - Uruguay 7
AL - Albania 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
ET - Etiopia 6
GR - Grecia 6
IL - Israele 6
CR - Costa Rica 5
HU - Ungheria 5
KZ - Kazakistan 5
LB - Libano 5
SC - Seychelles 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
GE - Georgia 4
LK - Sri Lanka 4
NG - Nigeria 4
NI - Nicaragua 4
NP - Nepal 4
PE - Perù 4
SN - Senegal 4
BB - Barbados 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
MO - Macao, regione amministrativa speciale della Cina 3
PA - Panama 3
PR - Porto Rico 3
SO - Somalia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GA - Gabon 2
GD - Grenada 2
GT - Guatemala 2
Totale 22.059
Città #
Ann Arbor 1.578
Singapore 1.175
Ashburn 986
San Jose 589
Hong Kong 583
Milan 490
Chandler 466
Fairfield 455
Woodbridge 415
Ho Chi Minh City 395
Frankfurt am Main 393
Wilmington 359
Houston 351
Toronto 326
Dublin 306
Hanoi 271
New York 243
Dearborn 234
Los Angeles 227
Santa Clara 205
Seattle 198
Dallas 196
Beijing 178
Jacksonville 170
Cambridge 161
Chicago 129
The Dalles 126
Hefei 117
Boardman 116
Princeton 113
Shanghai 109
Lissone 101
Vienna 98
Nanjing 87
Rome 81
Lauterbourg 78
Council Bluffs 73
São Paulo 73
Buffalo 66
Seoul 64
Munich 62
Da Nang 55
Altamura 51
Moscow 50
Lawrence 49
Orem 49
Columbus 44
Montreal 44
London 43
Guangzhou 40
Fremont 38
Monza 37
Chennai 35
Haiphong 35
Helsinki 34
San Diego 34
Tokyo 34
Warsaw 34
Brooklyn 33
Ottawa 32
Jakarta 31
Atlanta 29
Nanchang 29
Amsterdam 28
Johannesburg 28
Denver 27
Lachine 27
Nuremberg 27
Falls Church 26
Biên Hòa 24
Boston 24
Stockholm 24
Brussels 23
Jinan 23
Shenyang 23
Turku 23
Ha Long 22
Paris 22
Poplar 22
Baghdad 21
Bologna 21
Dhaka 21
Dong Ket 21
Nairobi 21
Manchester 20
Rio de Janeiro 20
Florence 19
Mumbai 19
Tashkent 19
Andover 18
Hangzhou 18
Kunming 18
Tianjin 18
Washington 18
Brno 17
Ningbo 17
Ninh Bình 17
Phoenix 17
Pune 17
Bắc Ninh 16
Totale 14.089
Nome #
Cognitive profile and metabolic brain imaging in late-onset PCA compared with early-onset PCA and senile amnesic AD 557
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 541
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 495
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 485
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 463
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 457
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 455
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 438
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 430
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 413
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 413
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 401
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 380
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 371
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 371
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 369
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 368
Neurocognitive heterogeneity of Posterior Cortical Atrophy 365
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 360
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 359
Sentinel node biopsy in endometrial cancer: an update 355
Motion management in PET/CT: Technological solutions 355
Respiratory motion management in PET/CT: applications and clinical usefulness 354
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 348
Mapping category fluency to the ventral and dorsal language streams in PCA and semantic and logopenic PPA 346
Metabolic subtypes of Posterior Cortical Atrophy: a data-driven approach controlling for pathophysiology-related hypometabolism 346
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 346
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 344
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 337
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 327
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 326
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 325
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 325
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 315
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 313
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 313
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 303
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 295
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 287
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 282
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 280
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 275
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 273
Cognitive profile of right and left Corticobasal Syndrome 272
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 270
[ 11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: Comparison with bone scintigraphy 270
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 266
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 265
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 263
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 262
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 258
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 256
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 256
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 254
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 253
Focal bone lesions in hiv-positive patient treated with tenofovir 244
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 243
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 234
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 233
PET-CT for treatment planning in prostate cancer 227
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 225
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 205
Molecular imaging in prostate cancer: [11C]choline PET/CT 203
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 198
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 196
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 191
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 189
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 185
Respiratory Gating and the performance of PET/CT in pulmonary lesions 180
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 178
PET-Guided target delineation in a patient with lung cancer. 142
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 133
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 126
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 108
Totale 22.646
Categoria #
all - tutte 67.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.000 0 140 110 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/20253.179 155 334 169 136 207 181 236 112 273 582 307 487
2025/20269.263 1.401 623 686 1.002 1.040 433 1.309 351 633 696 566 523
2026/2027330 248 82 0 0 0 0 0 0 0 0 0 0
Totale 22.646